zolpidem has been researched along with Behavior Disorders in 12 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Predictors were calculated in 6-month intervals and exactly 6 months before a drug overdose: opioid use (mean daily morphine-equivalent dose), benzodiazepine use (days' supply), antidepressant use (days' supply), zolpidem use (days' supply), mental health disorders (depression, anxiety/PTSD, psychosis), pain-related conditions, and substance use disorders (alcohol, other drug)." | 3.81 | Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders. ( Liang, Y; Turner, BJ, 2015) |
| "Chronic insomnia is a prevalent disorder associated with significant psychosocial, health, and economic impacts." | 2.82 | Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial. ( Beaulieu-Bonneau, S; Buysse, DJ; Edinger, JD; Ivers, H; Krystal, AD; Morin, CM, 2016) |
| "Insomnia is a cardinal symptom for many psychiatric disorders, especially depressive disorders." | 2.41 | A psychiatric perspective on insomnia. ( McCall, WV, 2001) |
| "In particular, patients with chronic insomnia have higher rates of psychiatric and medical illnesses, and insomnia is an important risk factor in the development of depression." | 2.41 | Consequences of insomnia and its therapies. ( Benca, RM, 2001) |
| "Comorbid psychiatric illness was diagnosed in 67 patients (39." | 1.46 | Benzodiazepine and "Z-Drug" Dependence: Data From a Tertiary Care Center. ( Benegal, V; Bokka, S; Chand, P; Kandasamy, A; Murthy, P; Shukla, L; Shukla, T, 2017) |
| "Zolpidem is a widely used ultrashort-acting non-benzodiazepine in clinical practice; compared with benzodiazepines, it does not have side effects such as daytime hangover, rebound insomnia, and development of tolerance." | 1.42 | [An Autopsy Case of Abnormal Behaviour Induced by Zolpidem]. ( Ikeda, N; Kudo, K; Sameshima, N; Sato, K; Tsuji, A; Usumoto, Y, 2015) |
| "Zolpidem is a short acting hypnotic drug belonging to imidazopyridine family." | 1.34 | Seizure following sudden zolpidem withdrawal. ( Cubała, WJ; Landowski, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanda, D | 1 |
| Zajdel, P | 1 |
| Soural, M | 1 |
| Schepis, TS | 1 |
| Turner, BJ | 1 |
| Liang, Y | 1 |
| Motamedi, GK | 1 |
| Wheeler, MG | 1 |
| Usumoto, Y | 1 |
| Kudo, K | 1 |
| Sameshima, N | 1 |
| Sato, K | 1 |
| Tsuji, A | 1 |
| Ikeda, N | 1 |
| Morin, CM | 1 |
| Edinger, JD | 1 |
| Krystal, AD | 1 |
| Buysse, DJ | 1 |
| Beaulieu-Bonneau, S | 1 |
| Ivers, H | 1 |
| Shukla, L | 1 |
| Bokka, S | 1 |
| Shukla, T | 1 |
| Kandasamy, A | 1 |
| Chand, P | 1 |
| Benegal, V | 1 |
| Murthy, P | 1 |
| Poceta, JS | 1 |
| Jang, M | 1 |
| Chang, H | 1 |
| Yang, W | 1 |
| Choi, H | 1 |
| Kim, E | 1 |
| Yu, BH | 1 |
| Oh, Y | 1 |
| Chung, H | 1 |
| Cubała, WJ | 1 |
| Landowski, J | 1 |
| McCall, WV | 1 |
| Benca, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sequenced Therapies for Comorbid and Primary Insomnias[NCT01651442] | 211 participants (Actual) | Interventional | 2012-08-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Insomnia Severity Index (ISI) is a self-report questionnaire assessing the nature, severity, and impact of insomnia. Remission is determined to be a score less-than 8. (NCT01651442)
Timeframe: 6 weeks, 12 weeks, 3 months, 6 months, 9 months & 12 months
| Intervention | percent remitted (Number) |
|---|---|
| Non-drug Sleep Therapy 1 | 40.00 |
| Sleep Medication 1 | 34.94 |
| Sleep Medication 1 Plus Non-drug Sleep Therapy 1 | 37.04 |
| Sleep Medication 1 Plus Sleep Medication 2 | 48.15 |
| Non-drug Sleep Therapy 1 Plus Non-drug Sleep Therapy 1 | 44.44 |
| Non-drug Sleep Therapy 1 Plus Sleep Medication 1 | 55.56 |
3 reviews available for zolpidem and Behavior Disorders
| Article | Year |
|---|---|
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
Topics: Animals; Clinical Trials as Topic; Drug Design; Humans; Imidazoles; Ligands; Mental Disorders; Molec | 2019 |
A psychiatric perspective on insomnia.
Topics: Acetamides; Benzodiazepines; Comorbidity; Depressive Disorder; Diagnosis, Differential; GABA-A Recep | 2001 |
Consequences of insomnia and its therapies.
Topics: Acetamides; Circadian Rhythm; Comorbidity; Half-Life; Health Status Indicators; Humans; Hypnotics an | 2001 |
1 trial available for zolpidem and Behavior Disorders
| Article | Year |
|---|---|
Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.
Topics: Adult; Affect; Clinical Protocols; Cognitive Behavioral Therapy; Colorado; Combined Modality Therapy | 2016 |
8 other studies available for zolpidem and Behavior Disorders
| Article | Year |
|---|---|
Age cohort differences in the nonmedical use of prescription zolpidem: findings from a nationally representative sample.
Topics: Adolescent; Adolescent Behavior; Adult; Age Distribution; Child; Cohort Studies; Cross-Sectional Stu | 2014 |
Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders.
Topics: Adolescent; Adult; Analgesics, Opioid; Antidepressive Agents; Benzodiazepines; Drug Overdose; Female | 2015 |
Daily episodes of confusion · altered behavior · chronic sleep deprivation · Dx?
Topics: Confusion; Diagnosis, Differential; Humans; Hypnotics and Sedatives; Male; Medication Errors; Mental | 2015 |
[An Autopsy Case of Abnormal Behaviour Induced by Zolpidem].
Topics: Accidents; Aged; Autopsy; Humans; Male; Mental Disorders; Pyridines; Sleep Initiation and Maintenanc | 2015 |
Benzodiazepine and "Z-Drug" Dependence: Data From a Tertiary Care Center.
Topics: Acetamides; Adult; Azabicyclo Compounds; Bacterial Proteins; Benzodiazepines; Female; Humans; Hypnot | 2017 |
Zolpidem ingestion, automatisms, and sleep driving: a clinical and legal case series.
Topics: Adult; Aged; Automatism; Automobile Driving; Female; Follow-Up Studies; Headache; Humans; Hypnotics | 2011 |
Development of an LC-MS/MS method for the simultaneous determination of 25 benzodiazepines and zolpidem in oral fluid and its application to authentic samples from regular drug users.
Topics: Benzodiazepines; Chromatography, Liquid; Humans; Mental Disorders; Mouth; Pyridines; Reproducibility | 2013 |
Seizure following sudden zolpidem withdrawal.
Topics: Adult; Female; Humans; Hypnotics and Sedatives; Mental Disorders; Pyridines; Seizures; Substance Wit | 2007 |